Human T-cell leukemia virus type 1 Tax transactivates the matrix metalloproteinase 7 gene via JunD/AP-1 signaling

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 5, 2011, Pages 731-741

  Nakachi, Sawako ^a,b   Nakazato, Tetsuro ^a,b   Ishikawa, Chie ^a   Kimura, Ryuichiro ^a   Mann, Derek A ^c   Senba, Masachika ^d   Masuzaki, Hiroaki ^b   Mori, Naoki ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d NAGASAKI UNIVERSITY   (Japan)

Author keywords

AP 1; ATL; HTLV 1; JunD; MMP 7; Tax

Indexed keywords

MATRILYSIN; TAX PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR JUND;

ARTICLE; BINDING SITE; CANCER INVASION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEGRADATION; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T CELL LEUKEMIA; VISCERA;

ADULT; ANTIBODIES, NEUTRALIZING; CELL LINE; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, LEUKEMIC; GENE PRODUCTS, TAX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MATRIX METALLOPROTEINASE 7; PHYTOHEMAGGLUTININS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-JUN; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTIONAL ACTIVATION;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 79955654087     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.02.002     Document Type: Article

References (40)

1. Yoshida M., Miyoshi I., Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl Acad. Sci. USA 1982, 79:2031-2035.
2. Bazarbachi A., Hermine O. Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives. Virus Res. 2001, 78:79-92.
3. Ii M., Yamamoto H., Adachi Y., Maruyama Y., Shinomura Y. Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp. Biol. Med. (Maywood) 2006, 231:20-27.
4. Liotta L.A., Steeg P.S., Stetler-Stevenson W.G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991, 64:327-336.
5. Hayashibara T., Yamada Y., Onimaru Y., Tsutsumi C., Nakayama S., Mori N., Miyanishi T., Kamihira S., Tomonaga M., Maita T. Matrix metalloproteinase-9 and vascular endothelial growth factor: a possible link in adult T-cell leukaemia cell invasion. Br. J. Haematol. 2002, 116:94-102.
6. Nabeshima K., Suzumiya J., Nagano M., Ohshima K., Toole B.P., Tamura K., Iwasaki H., Kikuchi M. Emmprin, a cell surface induced of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas. J. Pathol. 2004, 202:341-351.
7. Hernandez J.M., Floyd D.H., Weilbaecher K.N., Green P.L., Boris-Lawrie K. Multiple facets of junD gene expression are atypical among AP-1 family members. Oncogene 2008, 27:4757-4767.
8. Miyoshi I., Kubonishi I., Yoshimoto S., Akagi T., Ohtsuki Y., Shiraishi Y., Nagata K., Hinuma Y. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 1981, 294:770-771.
9. Koeffler H.P., Chen I.S.Y., Golde D.W. Characterization of a novel HTLV-infected cell line. Blood 1984, 64:482-490.
10. Miyoshi I., Kubonishi I., Sumida M., Hiraki S., Tsubota T., Kimura I., Miyamoto K., Sato J. A novel T-cell line derived from adult T-cell leukaemia. Gann 1980, 71:155-156.
11. Sugamura K., Fujii M., Kannagi M., Sakitani M., Takeuchi M., Hinuma Y. Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus. Int. J. Cancer 1984, 34:221-228.
12. Katoh T., Harada T., Morikawa S., Wakutani T. IL-2- and IL-2-R- independent proliferation of T-cell lines from adult T-cell leukemia/lymphoma patients. Int. J. Cancer 1986, 38:265-274.
13. Yoshida T., Miyagawa E., Yamaguchi K., Kobayashi S., Takahashi Y., Yamashita A., Miura H., Itoyama Y., Yamamoto N. IL-2 independent transformation of a unique human T cell line, TY8-3, and its subclones by HTLV-I and -II. Int. J. Cancer 2001, 91:99-108.
14. Ohtani K., Nakamura M., Saito S., Nagata K., Sugamura K., Hinuma Y. Electroporation: application to human lymphoid cell lines for stable introduction of a transactivator gene of human T-cell leukemia virus type I. Nucleic Acids Res. 1989, 17:1589-1604.
15. Tanaka Y., Yoshida A., Takayama Y., Tsujimoto H., Tsujimoto A., Hayami M., Tozawa H. Heterogeneity of antigen molecules recognized by anti-tax1 monoclonal antibody Lt-4 in cell lines bearing human T cell leukemia virus type I and related retroviruses. Jpn. J. Cancer Res. 1990, 81:225-231.
16. Matsumoto K., Shibata H., Fujisawa J.I., Inoue H., Hakura A., Tsukahara T., Fujii M. Human T-cell leukemia virus type 1 Tax protein transforms rat fibroblasts via two distinct pathways. J. Virol. 1997, 71:4445-4451.
17. Smart D.E., Vincent K.J., Arthur M.J.P., Eickelberg O., Castellazzi M., Mann J., Mann D.A. JunD regulates transcription of the tissue inhibitor of metalloproteinases-1 and interleukin-6 genes in activated hepatic stellate cells. J. Biol. Chem. 2001, 276:24414-24421.
18. 2α in ovarian cells. J. Biol. Chem. 2002, 277:3293-3302.
19. Vandel L., Montreau N., Vial E., Pfarr C.M., Binetruy B., Castellazzi M. Stepwise transformation of rat embryo fibroblasts: c-Jun, JunB, or JunD can cooperate with Ras for focus formation, but a c-Jun-containing heterodimer is required for immortalization. Mol. Cell. Biol. 1996, 16:1881-1888.
20. Crawford H.C., Fingleton B., Gustavson M.D., Kurpios N., Wagenaar R.A., Hassell J.A., Matrisian L.M. The PEA3 subfamily of Ets transcription factors synergizes with β-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors. Mol. Cell. Biol. 2001, 21:1370-1383.
21. Okamoto S., Mukaida N., Yasumoto K., Rice N., Ishikawa Y., Horiguchi H., Murakami S., Matsushima K. The interleukin-8 AP-1 and κB-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization. J. Biol. Chem. 1994, 269:8582-8589.
22. Mori N., Prager D. Transactivation of the interleukin-1α promoter by human T-cell leukemia virus type I and type II Tax proteins. Blood 1996, 87:3410-3417.
23. Smith M.R., Greene W.C. Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes. Genes Dev. 1990, 4:1875-1885.
24. Iwai K., Mori N., Oie M., Yamamoto N., Fujii M. Human T-cell leukemia virus type 1 tax protein activates transcription through AP-1 site by inducing DNA binding activity in T cells. Virology 2001, 279:38-46.
25. Benbow U., Brinckerhoff C.E. The AP-1 site and MMP gene regulation: what is all the fuss about?. Matrix Biol. 1997, 15:519-526.
26. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 1995, 270:16483-16486.
27. Pyrzynska B., Mosieniak G., Kaminska B. Changes of the trans-activating potential of AP-1 transcription factor during cyclosporin A-induced apoptosis of glioma cells are mediated by phosphorylation and alterations of AP-1 composition. J. Neurochem. 2000, 74:42-51.
28. Yazgan O., Pfarr C.M. Differential binding of the Menin tumor suppressor protein to JunD isoforms. Cancer Res. 2001, 61:916-920.
29. Leppä S., Saffrich R., Ansorge W., Bohmann D. Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation. EMBO J. 1998, 17:4404-4413.
30. Vinciguerra M., Vivacqua A., Fasanella G., Gallo A., Cuozzo C., Morano A., Maggiolini M., Musti A.M. Differential phosphorylation of c-Jun and JunD in response to the epidermal growth factor is determined by the structure of MAPK targeting sequences. J. Biol. Chem. 2004, 279:9634-9641.
31. Wilson C.L., Matrisian L.M. Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int. J. Biochem. Cell Biol. 1996, 28:123-136.
32. Rivat C., Le Floch N., Sabbah M., Teyrol I., Redeuilh G., Bruyneel E., Mareel M., Matrisian L.M., Crawford H.C., Gespach C., Attoub S. Synergistic cooperation between the AP-1 and LEF-1 transcription factors in activation of the matrilysin promoter by the src oncogene: implications in cellular invasion. FASEB J. 2003, 17:1721-1723.
33. Zhang J., Yamada O., Matsushita Y., Chagan-Yasutan H., Hattori T. Transactivation of human osteopontin promoter by human T-cell leukemia virus type 1-encoded Tax protein. Leuk. Res. 2010, 34:763-768.
34. Hall W.W., Fujii M. Deregulation of cell-signaling pathways in HTLV-1 infection. Oncogene 2005, 24:5965-5975.
35. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 2000, 103:239-252.
36. Thompson M., Xu D., Williams B.R.G. ATF3 transcription factor and its emerging roles in immunity and cancer. J. Mol. Med. 2009, 87:1053-1060.
37. Larocca D., Chao L.A., Seto M.H., Brunck T.K. Human T-cell leukemia virus minus strand transcription in infected T-cells. Biochem. Biophys. Res. Commun. 1989, 163:1006-1013.
38. Satou Y., Yasunaga J., Yoshida M., Matsuoka M. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc. Natl. Acad. Sci. USA 2006, 103:720-725.
39. Arnold J., Yamamoto B., Li M., Phipps A.J., Younis I., Lairmore M.D., Green P.L. Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1. Blood 2006, 107:3976-3982.
40. Thébault S., Basbous J., Hivin P., Devaux C., Mesnard J.M. HBZ interacts with JunD and stimulates its transcriptional activity. FEBS Lett. 2004, 562:165-170.